Nurse-Led Prehabilitation Before Major Abdominal Cancer Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlexandria University

About this trial

Many people who have major planned surgery for abdominal cancer develop complications afterwards, which can prolong hospital stay and slow recovery. This study tests whether a four-week program led by a trained oncology nurse, started before surgery, reduces these complications. The program combines supervised and home exercise (walking, resistance and breathing exercises), nutrition counseling with protein targets and supplements when needed, education and relaxation techniques to reduce anxiety, and advice on stopping smoking and alcohol. Adults at one hospital will be randomly assigned, in equal numbers, to the program plus usual care or to usual care alone; 104 participants are planned. The main outcome is the Comprehensive Complication Index, a score from 0 to 100 that combines all complications within 30 days after surgery, graded by an assessor who does not know the group. Other outcomes include serious complications, distance walked in six minutes, quality of life, length of hospital stay, hospital readmission, time to first getting out of bed, and adherence to the program. In a qualitative part, 12 to 15 participants from the program group will be interviewed about their experiences, barriers and acceptability. Results from both parts will be combined to interpret the findings.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 18 years or older

Histologically confirmed or suspected abdominal cancer (colorectal, gastric, pancreatic or hepatobiliary, or other major abdominal resection)

Scheduled for elective major open or laparoscopic abdominal surgery, with at least 3 weeks between enrollment and the planned surgery date

ECOG performance status 0 to 2

Disqualifiers

Emergency or urgent surgery

Unstable cardiac or respiratory disease, or any medical contraindication to exercise as judged by the treating physician

Severe musculoskeletal or neurological condition preventing walking

Cognitive impairment that prevents following the program or completing questionnaires

Trial design

Design model

Parallel

Treatments tested in this trial

  • Nurse-Led Multimodal Prehabilitation Program

    Behavioral

    A four-week program delivered by a trained oncology nurse from enrollment until the day before surgery, with a weekly nurse contact (in person or by phone) that reinforces the program and records adherence. Components: (1) Exercise: aerobic brisk walking 30 minutes, 5 days per week at moderate intensity (Borg rating of perceived exertion 11 to 14), resistance exercises 2 to 3 days per week, and daily breathing exercises, taught in a weekly supervised session and continued at home. (2) Nutrition: counseling guided by the Malnutrition Universal Screening Tool, protein target 1.2 to 1.5 g/kg/day, and oral nutritional supplements for medium or high risk, with counseling at baseline and weekly follow-up. (3) Psychological and educational: one preoperative education session about surgery and recovery plus weekly reinforcement, with relaxation and anxiety-reduction techniques. (4) Lifestyle: smoking and alcohol cessation advice where relevant, at baseline and weekly.

Treatment groups

104 Participants
are divided into 2 treatment groups
Group A: Nurse-Led Multimodal PrehabilitationExperimental treatment 1 intervention
Group B: Usual CareNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Comprehensive Complication Index (CCI)

Comprehensive Complication Index, a single score for each patient from 0 (no complication) to 100 (death), calculated from all postoperative complications within 30 days after surgery graded by the Clavien-Dindo classification. Higher scores mean worse outcomes. Graded from the medical record by an assessor masked to group.

Time frame
Postoperative day 30

Secondary outcomes

1

Major Complications

Proportion of patients with at least one major complication, defined as Clavien-Dindo Grade III to V

Time frame
Postoperative day 30
2

Change in 6-Minute Walk Distance, Baseline to Pre-Operative

Change in distance walked in 6 minutes (meters) between baseline (T0) and 24 to 48 hours before surgery (T1). Higher is better

Time frame
From baseline (T0) to 24 to 48 hours before surgery (T1)
3

Health-Related Quality of Life (EORTC QLQ-C30, version 3.0)

Change in scores from baseline (T0) to follow-up (T3). All scales are transformed to 0 to 100. Higher scores on functional scales and global health status mean better functioning, and higher scores on symptom scales mean more symptoms

Time frame
Baseline (T0) and 6 to 8 weeks after surgery (T3)

Other outcomes

1

Participant Experiences of the Program (Qualitative)

Experiences, adherence, barriers and acceptability explored in semi-structured individual interviews with 12 to 15 intervention-group participants, analyzed by reflexive thematic analysis

Time frame
After the 6 to 8 week follow-up visit (T3)

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: